Successful trial of new immunotherapy treatment
Successful trial of a new immunotherapy drug which offers a third, and less toxic, option for the treatment of advanced melanoma.
Successful trial of a new immunotherapy drug which offers a third, and less toxic, option for the treatment of advanced melanoma.
MIA Co-Medical Director, Professor Georgina Long, who has been recognised in the 2020 Queen’s Birthday Honours List.
MIA's world leading researchers receive NHMRC grants to further their melanoma research, taking us closer to reaching zero deaths from melanoma.